All In Biotech

Drug Trial Radar · NCT00605956

NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers

An Evaluation of the Photoallergy Potential of NatrOVA Creme Rinse - 1% in Healthy Volunteers

Last checked: Nov 20, 2026Latest source record: Aug 4, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

65

Planned (sponsor's estimate)

Start

Jan 2008

Primary completion

Feb 2008

Study completion Feb 2008

Sponsor

Lead sponsor
ParaPRO LLCIndustry
Sponsor type
Industry
First posted
Feb 1, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Photoallergic reactions are assumed to be due to a delayed cell-mediated hypersensitivity response that requires the presence of ultraviolet irradiation. The predictive procedure is, therefore, based on modification of the Repeated Insult Patch Test (Kaidbey, 1991). Duplicate sets of patches of test articles are used with exposure of only one set to UV radiation and subsequent evaluation of both sets for skin reactions in order to compare irradiated versus non-irradiated test sites.

Conditions

  • Head Lice

Interventions

  • NatrOVA Creme Rinse - 1%Drug

    NatrOVA Creme Rinse - 1% spinosad

  • NatrOVA Creme Rinse Vehicle OnlyDrug

    NatrOVA Creme Rinse Vehicle - no spinosad

  • Blank PatchDrug

    Blank Patch

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual grading of test site and assessments of adverse experiencesTime frame: Evaluations over a 6 week period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hill Top Research

    St. Petersburg, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.